Market Place
Sourcing Support
Johnson & Johnson to Host Investor Conference Call on Q1 Results
02 Mar 2026 //
BUSINESSWIRE
Johnson & Johnson Reports Promising Antitumor Activity
26 Feb 2026 //
PR NEWSWIRE
GSK Props Up Its Cabenuva In Adolescents With Long-Term Data
26 Feb 2026 //
FIERCE PHARMA
Johnson & Johnson Seeks FDA Approval For IMAAVY In wAIHA Anemia
25 Feb 2026 //
PR NEWSWIRE
EC Approves SC RYBREVANT for EGFR NSCLC Cancer
24 Feb 2026 //
PHARMIWEB
Bayer Sues J&J Over `Deeply Flawed` Erleada Promotional Claims
23 Feb 2026 //
FIERCE PHARMA
Guselkumab Maintains Ulcerative Colitis Remission For 3 Years
21 Feb 2026 //
PR NEWSWIRE
Rybrevant Faspro Earns FDA Breakthrough Therapy Designation
19 Feb 2026 //
PHARMIWEB
FDA Untitled Letter Lambastes Claims In Ad For J&J`s Tremfya
19 Feb 2026 //
FIERCE PHARMA
EMA Seeks Input On Drafting Myasthenia Gravis Trial Guide
19 Feb 2026 //
RAPS
J&J Halts Enrollment in Trial of AC Immune Alzheimer`s drug
19 Feb 2026 //
FIERCE BIOTECH
J&J to invest $1 billion in new Pennsylvania plant
18 Feb 2026 //
REUTERS
Law firm in J&J baby powder cases sues its litigation funders
13 Feb 2026 //
REUTERS
J&J Liable In Pennsylvania Talc Cancer Trial
13 Feb 2026 //
REUTERS
Philly Jury Awards $250K vs. J&J in Baby Powder Trial
13 Feb 2026 //
BUSINESSWIRE
J&J`s Tremfya Roars Into 2026 With Massive January TV Ad Spend
11 Feb 2026 //
FIERCE PHARMA
Johnson & Johnson Joins Barclays Global Healthcare Conference
09 Feb 2026 //
BUSINESSWIRE
Abbvie CSO Highlights Breakthrough Psychedelic Therapy; J&J`s
06 Feb 2026 //
BIOSPACE
The Biggest Potential Drug Launches Of 2026
06 Feb 2026 //
FIERCE PHARMA
Johnson & Johnson Unveils OMNY-AF Pilot Study Results At 2026 AF
06 Feb 2026 //
BUSINESSWIRE
BMS, J&J Factor In HCP Education Before Milvexian Data Drop
03 Feb 2026 //
FIERCE PHARMA
Head-to-Head Analysis shows 51% reduction in Risk of Death
02 Feb 2026 //
PR NEWSWIRE
Johnson & Johnson at TD Cowen 46th Healthcare Conference
02 Feb 2026 //
BUSINESSWIRE
Johnson & Johnson receives CHMP positive opinion for AKEEGA
30 Jan 2026 //
GLOBENEWSWIRE
J&J’s Darzalex Faspro Notches Another Multiple Myeloma Indication
28 Jan 2026 //
PR NEWSWIRE
J&J`s $100M MedTech Donations Since 2020 Save Lives, Restore
27 Jan 2026 //
BUSINESSWIRE
Resolve M Therapeutics Exits From Stealth
22 Jan 2026 //
PHARMIWEB
J&J Targets $100B Sales, Overcomes Stelara Patent Cliff
22 Jan 2026 //
BIOSPACE
Expert Testimony Will Be Allowed In J&J Talc Litigation In N.J.
22 Jan 2026 //
FIERCE PHARMA
Johnson & Johnson Reports Q4 And Full-Year 2025 Results
21 Jan 2026 //
BUSINESSWIRE
Genmab Announces Net Sales Of DARZALEX (Daratumumab) For 2025
21 Jan 2026 //
GLOBENEWSWIRE
New Data Spotlights CAPLYTA For Remission in MDD Disorder
16 Jan 2026 //
PR NEWSWIRE
TECVAYLI Surpasses Standard of Care in R/R Multiple Myeloma
14 Jan 2026 //
PR NEWSWIRE
Johnson & Johnson Advances Depression Leadership With New Data
13 Jan 2026 //
PR NEWSWIRE
Johnson & Johnson Announces Multibillion Dollar Facility in NC
13 Jan 2026 //
CONTRACTPHARMA
Veristat Names Kim McLean Boericke as CEO
13 Jan 2026 //
CONTRACTPHARMA
RYBREVANT Shows Promising, Durable Responses in Colorectal Cancer
10 Jan 2026 //
PR NEWSWIRE
J&J Reveals US Drug Pricing Deal And Plans To Build 2 US Plants
09 Jan 2026 //
FIERCE PHARMA
Johnson & Johnson Enhances Medicine Access And Lowers Costs
09 Jan 2026 //
PHARMIWEB
Lexeo, J&J Team Up On Heart Pump Tech For Gene Therapy Delivery
08 Jan 2026 //
GLOBENEWSWIRE
J&J, Google Venture Arms Line Up To Back Epibiologics` Series B
08 Jan 2026 //
FIERCE BIOTECH
Lilly, J&J Top Clarivate`s 2026 Drugs to Watch
07 Jan 2026 //
FIERCE PHARMA
J&J Seeks FDA Clearance for OTTAVA Robotic Surgical System
07 Jan 2026 //
BUSINESSWIRE
Bayer Sues Moderna, J&J And Pfizer/Biontech Over COVID Vax Tech
07 Jan 2026 //
FIERCE PHARMA
J&J Submits EMA Application for TECVAYLI Combo in Myeloma
06 Jan 2026 //
GLOBENEWSWIRE
Johnson & Johnson Reveals Nipocalimab As First FcRn Blocker
06 Jan 2026 //
PR NEWSWIRE
J&J`s Tremfya Closes Out 2025 As December`s Top TV Ad Spender
06 Jan 2026 //
FIERCE PHARMA
Johnson & Johnson Declares Q1 2026 Dividend
02 Jan 2026 //
BUSINESSWIRE
Johnson & Johnson Completes Acquisition of Halda Therapeutics
29 Dec 2025 //
BUSINESSWIRE
J&J Halts Mid-stage Trial of Experimental Eczema Drug
27 Dec 2025 //
REUTERS
J&J vows appeal after US jury hits it with record $1.5B talc
27 Dec 2025 //
REUTERS
Europe Greenlights TREMFYA For Pediatric Plaque Psoriasis
19 Dec 2025 //
PHARMIWEB
Minnesota Jury Awards $65.5M vs. Johnson & Johnson
19 Dec 2025 //
BUSINESSWIRE
FDA Approves RYBREVANT + LAZCLUZE for Shortest First-Line Dosing
17 Dec 2025 //
PR NEWSWIRE
Janssen’s Biologics Rybrevant Faspro Receives Approval in US
17 Dec 2025 //
FDA
Link Cell Therapies Launches CAR-T for Solid, Liquid Tumors
15 Dec 2025 //
PR NEWSWIRE
Johnson & Johnson Hosts Investor Call On Q4 Results
15 Dec 2025 //
BUSINESSWIRE
FDA `Proactively` Awards J&J A National Priority Review Voucher
15 Dec 2025 //
FIERCE PHARMA
FDA Approves AKEEGA For BRCA2-Mutated Prostate Cancer
12 Dec 2025 //
PR NEWSWIRE
Majestec-3 Study Backs TECVAYLI With DARZALEX FASPRO
09 Dec 2025 //
PR NEWSWIRE
